Nanotherapeutics for Alleviating Anesthesia‐Associated Complications
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(15)
Published: Feb. 11, 2024
Abstract
Current
management
of
anesthesia‐associated
complications
falls
short
in
terms
both
efficacy
and
safety.
Nanomaterials
with
versatile
properties
unique
nano‐bio
interactions
hold
substantial
promise
as
therapeutics
for
addressing
these
complications.
This
review
conducts
a
thorough
examination
the
existing
nanotherapeutics
highlights
strategies
developing
prospective
nanomedicines
to
mitigate
anesthetics‐related
toxicity.
Initially,
general,
regional,
local
anesthesia
along
commonly
used
anesthetics
related
prevalent
side
effects
are
introduced.
Furthermore,
employing
nanotechnology
prevent
alleviate
is
systematically
demonstrated
from
three
aspects,
that
is,
1)
safe
nano‐formulization
anesthetics;
2)
nano‐antidotes
sequester
overdosed
alter
their
pharmacokinetics;
3)
pharmacodynamic
activities
treat
Finally,
prospects
challenges
facing
clinical
translation
anesthesia‐related
discussed.
work
provides
comprehensive
roadmap
effective
toxicity,
which
can
potentially
revolutionize
Language: Английский
Protective effects of diacerein against quinolinic acid–induced Huntington’s disease–like symptoms in adult zebrafish by targeting GSK-3β signalling
Falguni Goel,
No information about this author
Vaishali Dobhal,
No information about this author
Shamsher Singh
No information about this author
et al.
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
Language: Английский
Supported silver nanoparticles over starch-modified magnetic nanoparticles: Characterization, Its application for A3 coupling reactions, analgesic and anesthetic activities
Junwei Lu,
No information about this author
Meilan Zhang,
No information about this author
Attalla F. El‐kott
No information about this author
et al.
Journal of Organometallic Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 123544 - 123544
Published: Jan. 1, 2025
Language: Английский
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal,
No information about this author
Mukul Jain,
No information about this author
Y. Mir
No information about this author
et al.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 29, 2025
Neurodegenerative
diseases,
characterized
by
progressive
neuronal
loss
and
cognitive
impairments,
pose
a
significant
global
health
challenge.
This
study
explores
the
potential
of
nanotherapeutics
as
promising
approach
to
enhance
drug
delivery
across
physiological
barriers,
particularly
blood–brain
barrier
(BBB)
blood-cerebrospinal
fluid
(B-CSFB).
By
employing
nanoparticles,
this
research
aims
address
critical
challenges
in
diagnosis
treatment
conditions
such
Alzheimer’s,
Parkinson’s,
Huntington’s
diseases.
The
multifactorial
nature
these
disorders
necessitates
innovative
solutions
that
leverage
nanomedicine
improve
solubility,
circulation
time,
targeted
while
minimizing
off-target
effects.
findings
underscore
importance
advancing
applications
develop
effective
therapeutic
strategies
can
alleviate
burden
neurodegenerative
diseases
on
individuals
healthcare
systems.
Language: Английский
Clickable immune-microenvironment modulated hydrogels for spinal cord injury repair
Journal of Colloid and Interface Science,
Journal Year:
2024,
Volume and Issue:
679, P. 1079 - 1092
Published: Oct. 21, 2024
Language: Английский
Improvement of sleep duration and quality through GABAA receptor by whey protein hydrolysate containing DIQK as the active main compound
Hyowon Lee,
No information about this author
Hyeongyeong Kim,
No information about this author
Cheng-Min Jin
No information about this author
et al.
Journal of Dairy Science,
Journal Year:
2024,
Volume and Issue:
107(11), P. 8811 - 8823
Published: May 31, 2024
This
study
characterized
the
sleep
activity,
mechanism,
and
active
peptides
of
whey
protein
hydrolysates
selected
through
behavioral
analysis
fruit-flies
(Drosophila
melanogaster).
Sleep-inducing
(WP)
hydrolysate
was
fruit
fly
behavior
analysis,
activity
measured
using
a
pentobarbital
model
electroencephalographic
analysis.
The
mechanism
action
confirmed
γ-aminobutyric
acid
(GABA)
receptor
antagonist,
peptide
identified
liquid
chromatography-mass
spectroscopy.
Whey
hydrolysate,
prepared
Alcalase
Prozyme
(WP-AP),
increased
time
in
dose-dependent
manner.
WP-AP
significantly
not
only
but
also
slow-wave
showed
an
insomnia-alleviating
effect
caffeine-induced
insomnia
mouse
model.
In
addition,
gene
expression
levels
GABA
sub-type
A
(GABAA)
receptors
brains
mice
orally
administered
with
WP-AP.
Through
mixture
DIQK,
VPPF
peptide,
contained
estimated
to
exhibit
due
its
high
content,
DIQK
speculated
be
main
-inducing
ingredient.
These
results
indicate
that
has
potential
used
as
new
ingredient
improve
quality.
Language: Английский
Multidisciplinary integration of frontier technologies facilitating the development of anesthesiology and perioperative medicine in aging society
Lize Xiong,
No information about this author
Jun‐Li Cao,
No information about this author
Hailong Dong
No information about this author
et al.
Fundamental Research,
Journal Year:
2024,
Volume and Issue:
4(4), P. 795 - 796
Published: June 5, 2024
Language: Английский
Dendritic Molecular Baskets for Selective Binding of Toxic Methotrexate
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 12, 2024
We
describe
the
preparation,
assembly,
recognition
characteristics,
and
bioactivity
of
dendritic
basket
6
Language: Английский
Dendritic Molecular Baskets for Selective Binding of Toxic Methotrexate
Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 12, 2024
Abstract
We
describe
the
preparation,
assembly,
recognition
characteristics,
and
bioactivity
of
dendritic
basket
6
12−
.
This
novel
cavitand
has
a
deep
aromatic
pocket
with
three
(
S
)‐glutamic
acid
dendrons
at
rim
to
amplify
water
solubility
prevent
self‐association.
1
H
NMR
spectroscopy,
calorimetry
(ITC),
mass
spectrometry
(ESI‐MS)
measurements
validate
formation
an
inclusion
complex
between
anticancer
drug
methotrexate
(MTX
2−
)
in
K
d
=9.2
μM).
To
identify
docking
pose,
comparison
computed
(DFT
MM)
experimental
chemical
shifts
suggests
that
MTX
folds
inside
(π⋅⋅⋅π),
forming
HBs
peptidic
while
anchoring
(C−H⋅⋅⋅π)
through
its
N‐methyl
group.
In
consequence,
selectively
binds
competition
structurally
similar
folic
leucovorin
(reversal
poisoning
agent).
While
host
is
biocompatible
(HEK293;
IC
50
>150
μM)
produces
[MTX⊂
]
14−
cell
media,
it
experiences
limitation
pharmacokinetic
sequestration
as
dihydrofolate
reductase's
affinity
suggested
prevail
over
Nonetheless,
considering
basket's
biocompatibility,
tunability,
chemoselectivity,
stands
leading
candidate
pursuit
effective
abiotic
antidote
for
poisoning.
Language: Английский